Loading…
Loading grant details…
| Funder | NATIONAL CANCER INSTITUTE |
|---|---|
| Recipient Organization | University of Tx Md Anderson Can Ctr |
| Country | United States |
| Start Date | Sep 19, 2023 |
| End Date | Aug 31, 2028 |
| Duration | 1,808 days |
| Number of Grantees | 3 |
| Roles | Co-Investigator; Principal Investigator |
| Data Source | NIH (US) |
| Grant ID | 10754783 |
Project Summary/Abstract Cervical cancer disproportionately affects women of color from low-socioeconomic geographical locations. Locations, such as sub-Saharan Africa, can also have a high incidence of Human Immunodeficiency Virus (HIV) infection, and access to cervical cancer screening is generally limited for women living in these underserved
communities. Furthermore, People Living with Human Immunodeficiency Virus (PLWH) have evidence of premature aging, which could contribute to cervical cancer progression and responses to chemoradiation therapy (CRT). CRT is the standard of care for locally advanced cervical cancer, and older women (≥52-years of age)
treated with CRT have worse side effects than younger (
University of Tx Md Anderson Can Ctr
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant